Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 19Breast Neoplasms 16Pain 8Agnosia 8Lung Neoplasms 6Prostatic Neoplasms 5Neoplasms 5Stomach Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 3Supratentorial Neoplasms 2Postoperative Complications 2Meningioma 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Sleep Deprivation 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pain, Intractable 1Ovarian Cysts 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Malignant Neoplasms of Male Genital Organs 1Liver Neoplasms 1Liver Diseases 1Leiomyoma 1Kidney Neoplasms 1Intraoperative Complications 1

Interventions

Surgical Procedures, Operative 1Sevoflurane 1Ropivacaine 1Propofol 1Paclitaxel 1Nitrous Oxide 1Lidocaine 1Iohexol 1Imatinib Mesylate 1Glycopyrrolate 1Food, Formulated 1Fluorouracil 1FS 069 1Enoxaparin 1Embolization, Therapeutic 1Doxorubicin 1Dietary Supplements 1Dexmedetomidine 1Cytoreduction Surgical Procedures 1Continuous Positive Airway Pressure 1Cisplatin 1Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Abdominal Neoplasms × Ropivacaine × Clear all
NCT06430112 2024-05-28

Liposomal Bupivacaine vs Ropivacaine for TAPBs

Sun Yat-sen University

Phase 3 Unknown
74 enrolled

Abdominal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡